Given the reported positive correlation between the CD8+ T-cell response against TB antigens and higher CD8+ T-cell responses in the context of recent exposure to M. tuberculosis [13,14], we postulated that the CD8+ response would be more sensitive to LTBI treatment compared with the CD4+ response. The gene discussed is CD4; the disease is tuberculosis.